Coronavirus (COVID-19)

This page contains medical information for clinicians on the 2019 Novel Coronavirus (COVID-19, also called 2019-nCoV, and now clinically SARS‐CoV‐2). This section includes articles that pertain to clinicians and cardiologists on the virus, new technologies being deployed to fight the virus and clinical information from various sources. Here are direct links for medical professionals to COVID-19 resources from the U.S. Food and Drug Administration (FDA)Centers for Disease Control (CDC) and the World Health Organization (WHO). Daily world-wide statistics on the coronavirus outbreak are available from the WHO Situations Reports. Here is the Centers for Medicare and Medicaid Services (CMS) frequently asked questions and answers (FAQs) for healthcare providers regarding Medicare payment for laboratory tests and other services related to the COVID-19.

The chat box in a the minutes prior to the beginning of the opening session of the ACC 2020 virtual meeting. Hundreds of clinicians said hello from their locations around the globe, keeping with the ACC  messaging on the screen. #ACC20 #ACC #ACC2020

The chat box in the minutes prior to the beginning of the ACC 2020 virtual meeting's opening session. Hundreds of clinicians said hello from their locations around the globe, keeping with the ACC messaging on the screen.

Blog | ACC | April 01, 2020
While the HRS annual meeting is cancelled, the society has created a resource page to help its members in the fight against COVID-19 at https://www.hrsonline.org/COVID19-Challenges-Solutions. #HRS #COVID19 #coronavirus #SARScov2

While the HRS annual meeting is cancelled, the society has created a resource page to help its members in the fight against COVID-19 at https://www.hrsonline.org/COVID19-Challenges-Solutions

Feature | Coronavirus (COVID-19) | April 01, 2020 | Dave Fornell, Editor

April 1, 2020 — Due to the continued global escalation of the novel coronavirus (COVID-19, SARS-CoV-2), the Heart...

William O’Neill, M.D., Henry Ford Hospital, speaking at the announcement of the creation of the Cardiogenic Shock Initiative in 2016. O'Neill asked the same partner hospitals in the Detroit area to pool resources to create a COVID-19 study group to help speed the gathering of data in COVID-19 drug trials.

William O’Neill, M.D., Henry Ford Hospital, speaking at the announcement of the creation of the Cardiogenic Shock Initiative in 2016. O'Neill asked the same partner hospitals in the Detroit area to pool resources to create a COVID-19 study group to help speed the gathering of data in COVID-19 drug trials.

News | Coronavirus (COVID-19) | March 31, 2020

March 31, 2020 — Four metropolitan Detroit hospital systems and a leading research university announced a...

The Edwards Lifesciences Cardioband for tricuspid valve regurgitation. #COVID19 #coronavirus

The Edwards Lifesciences Cardioband for tricuspid valve regurgitation is one of the device trials being paused for the duration of the COVID-19 outbreak.

News | Heart Valve Technology | March 30, 2020

March 30, 2020 — Edwards Lifesciences Corp. announced it is temporarily pausing new enrollments in its active...

AHA, ACC, HRS, SCAI and other medical societies call for federal government to do what is needed to get medical supplies to front-line clinicians fighting COVID-19. #COVID19 #SARScov2 #Coronavirus
News | Coronavirus (COVID-19) | March 30, 2020

March 30, 2020 — A group of 13 U.S. medical societies sent an open letter to Congress appealing to them to do what...

Italian Cardiologist Maurizio Galderisi Died From COVID-19, #coronavirus #COVID19
News | Coronavirus (COVID-19) | March 27, 2020

March 27, 2020 — In Italy today, novel coronavirus (COVID-19) claimed the life of well known cardiologist...

News | Coronavirus (COVID-19) | March 25, 2020 | Dave Fornell, Editor

March 25, 2020 — The U.S. Food and Drug Administration (FDA) said it is taking action to increase U.S. supplies of...

Hydroxychloroquine causes prolonged QT intervals and cardiac arrhythmias, so this needs to be considered in patients being treated with this drug for COVID-19. #COVID19 #SARScov2 #coronavirus

Hydroxychloroquine causes prolonged QT intervals and cardiac arrhythmias, so this needs to be considered in patients being treated with this drug for COVID-19.

Feature | Coronavirus (COVID-19) | March 24, 2020 | Marianne Pop, Pharm.D, BCPS

It has been more than three months since the word coronavirus was uttered on everyone’s lips and all over the social...

Medicare, CMS, calls for cancelling or postponing all elective or non-essential medical procedures, test and surgeries due to COVID-19. #COVID19 #SARcov2 #coronavirus #cardiology
Feature | Coronavirus (COVID-19) | March 20, 2020 | Dave Fornell, Editor
Videos | Coronavirus (COVID-19) | March 18, 2020

This is a quick overview of clinical data on the...

Overlay Init